AlphaStar Capital Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-23,096
Closed -$274K 340
2022
Q3
$274K Sell
23,096
-8,473
-27% -$128K 0.03% 250
2022
Q2
$482K Buy
31,569
+18,679
+145% +$336K 0.04% 227
2022
Q1
$272K Hold
12,890
0.02% 316
2021
Q4
$311K Buy
12,890
+871
+7% +$18.7K 0.02% 303
2021
Q3
$250K Buy
+12,019
New +$246K 0.02% 338
2020
Q4
Sell
-24,112
Closed -$426K 216
2020
Q3
$426K Buy
24,112
+1,494
+7% +$27.8K 0.09% 134
2020
Q2
$414K Buy
22,618
+804
+4% +$14.2K 0.09% 128
2020
Q1
$337K Buy
21,814
+1,843
+9% +$38.5K 0.08% 135
2019
Q4
$422K Buy
19,971
+1,359
+7% +$27.5K 0.09% 139
2019
Q3
$364K Sell
18,612
-873
-4% -$16K 0.09% 144
2019
Q2
$340K Buy
19,485
+310
+2% +$5.58K 0.09% 157
2019
Q1
$355K Sell
19,175
-481
-2% -$8.57K 0.1% 145
2018
Q4
$316K Sell
19,656
-2,135
-10% -$33.8K 0.1% 159
2018
Q3
$325K Buy
+21,791
New +$318K 0.1% 174

Other funds holding MPT

AlphaStar Capital Management's MPT Position: Q4 2022 in Review

AlphaStar Capital Management sold out of Medical Properties Trust (MPT) in Q4 2022, closing a stake of 23,096 shares — an estimated $274K sold.

AlphaStar Capital Management first reported a position in MPT in Q3 2018 and held it in 14 quarters. The position peaked at $482K in Q2 2022. 639 funds tracked by Wall St. Rank hold MPT as of Q4 2022.

  • AlphaStar Capital Management reported no remaining Medical Properties Trust position as of Q4 2022 after selling out during the quarter.
  • AlphaStar Capital Management sold 23,096 Medical Properties Trust shares in Q4 2022, an estimated $274K.
  • AlphaStar Capital Management first reported a position in Medical Properties Trust in Q3 2018 and held it in 14 quarters.
  • AlphaStar Capital Management's Medical Properties Trust position peaked at $482K in Q2 2022.
  • 639 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2022.

Based on AlphaStar Capital Management's 13F filing for Q4 2022, filed 8 Feb 2023.